Literature DB >> 27572703

Potential role of bioactive peptides in prevention and treatment of chronic diseases: a narrative review.

Arrigo F G Cicero1, Federica Fogacci1, Alessandro Colletti1.   

Abstract

In the past few years, increasing interest has been directed to bioactive peptides of animal and plant origin: in particular, researchers have focused their attention on their mechanisms of action and potential role in the prevention and treatment of cancer, cardiovascular and infective diseases. We have developed a search strategy to identify these studies in PubMed (January 1980 to May 2016); particularly those papers presenting comprehensive reviews or meta-analyses, plus in vitro and in vivo studies and clinical trials on those bioactive peptides that affect cardiovascular diseases, immunity or cancer, or have antioxidant, anti-inflammatory and antimicrobial effects. In this review we have mostly focused on evidence-based healthy properties of bioactive peptides from different sources. Bioactive peptides derived from fish, milk, meat and plants have demonstrated significant antihypertensive and lipid-lowering activity in clinical trials. Many bioactive peptides show selective cytotoxic activity against a wide range of cancer cell lines in vitro and in vivo, whereas others have immunomodulatory and antimicrobial effects. Furthermore, some peptides exert anti-inflammatory and antioxidant activity, which could aid in the prevention of chronic diseases. However, clinical evidence is at an early stage, and there is a need for solid pharmacokinetic data and for standardized extraction procedures. Further studies on animals and randomized clinical trials are required to confirm these effects, and enable these peptides to be used as preventive or therapeutic treatments. LINKED ARTICLES: This article is part of a themed section on Principles of Pharmacological Research of Nutraceuticals. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.11/issuetoc.
© 2016 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27572703      PMCID: PMC5429326          DOI: 10.1111/bph.13608

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  116 in total

1.  Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia.

Authors:  S B Malkowicz; W G McKenna; D J Vaughn; X S Wan; K J Propert; K Rockwell; S H Marks; A J Wein; A R Kennedy
Journal:  Prostate       Date:  2001-06-15       Impact factor: 4.104

Review 2.  The use of therapeutic peptides to target and to kill cancer cells.

Authors:  R J Boohaker; M W Lee; P Vishnubhotla; J M Perez; A R Khaled
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 3.  Cheese whey: A potential resource to transform into bioprotein, functional/nutritional proteins and bioactive peptides.

Authors:  Jay Shankar Singh Yadav; Song Yan; Sridhar Pilli; Lalit Kumar; R D Tyagi; R Y Surampalli
Journal:  Biotechnol Adv       Date:  2015-07-09       Impact factor: 14.227

Review 4.  Bioactive peptides derived from natural proteins with respect to diversity of their receptors and physiological effects.

Authors:  Masaaki Yoshikawa
Journal:  Peptides       Date:  2015-08-19       Impact factor: 3.750

5.  Identification of a hepatoprotective peptide in wheat gluten hydrolysate against D-galactosamine-induced acute hepatitis in rats.

Authors:  Kenji Sato; Yukari Egashira; Shin Ono; Satoshi Mochizuki; Yuki Shimmura; Yoshio Suzuki; Megumi Nagata; Kaori Hashimoto; Tamami Kiyono; Eun Young Park; Yasushi Nakamura; Mariko Itabashi; Yuka Sakata; Seigo Furuta; Hiroo Sanada
Journal:  J Agric Food Chem       Date:  2013-06-19       Impact factor: 5.279

6.  Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia.

Authors:  W B Armstrong; A R Kennedy; X S Wan; J Atiba; C E McLaren; F L Meyskens
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-01       Impact factor: 4.254

7.  Hydroxyproline-containing dipeptides and tripeptides quantified at high concentration in human blood after oral administration of gelatin hydrolysate.

Authors:  Satomi Ichikawa; Masashi Morifuji; Hiroki Ohara; Hitoshi Matsumoto; Yasuo Takeuchi; Kenji Sato
Journal:  Int J Food Sci Nutr       Date:  2010-02       Impact factor: 3.833

Review 8.  The role of nutrition, nutraceuticals, vitamins, antioxidants, and minerals in the prevention and treatment of hypertension.

Authors:  Mark C Houston
Journal:  Altern Ther Health Med       Date:  2013       Impact factor: 1.305

9.  The mechanisms by which pardaxin, a natural cationic antimicrobial peptide, targets the endoplasmic reticulum and induces c-FOS.

Authors:  Chen-Hung Ting; Han-Ning Huang; Tsui-Chin Huang; Chang-Jer Wu; Jyh-Yih Chen
Journal:  Biomaterials       Date:  2014-01-26       Impact factor: 12.479

10.  Lupin peptides lower low-density lipoprotein (LDL) cholesterol through an up-regulation of the LDL receptor/sterol regulatory element binding protein 2 (SREBP2) pathway at HepG2 cell line.

Authors:  Carmen Lammi; Chiara Zanoni; Graziana M Scigliuolo; Alfonsina D'Amato; Anna Arnoldi
Journal:  J Agric Food Chem       Date:  2014-07-11       Impact factor: 5.279

View more
  41 in total

1.  Principles of pharmacological research of nutraceuticals.

Authors:  Ruth Andrew; Angelo A Izzo
Journal:  Br J Pharmacol       Date:  2017-06       Impact factor: 8.739

2.  Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel.

Authors:  Arrigo F G Cicero; Alessandro Colletti; Gani Bajraktari; Olivier Descamps; Dragan M Djuric; Marat Ezhov; Zlatko Fras; Niki Katsiki; Michel Langlois; Gustavs Latkovskis; Demosthenes B Panagiotakos; Gyorgy Paragh; Dimitri P Mikhailidis; Olena Mitchenko; Bernhard Paulweber; Daniel Pella; Christos Pitsavos; Željko Reiner; Kausik K Ray; Manfredi Rizzo; Amirhossein Sahebkar; Maria-Corina Serban; Laurence S Sperling; Peter P Toth; Dragos Vinereanu; Michal Vrablík; Nathan D Wong; Maciej Banach
Journal:  Arch Med Sci       Date:  2017-08-04       Impact factor: 3.318

3.  Improvement of Resveratrol Effects When Combined with Rice Oil in Rat Models of Inflammation.

Authors:  Rodrigo B M Silva; Izaque S Maciel; Alice Ribeiro; Gabriel Rübensam; Andressa Bernardi; Fernanda B Morrone; Andre A Souto; Maria M Campos
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

4.  Anti-Pythium insidiosum activity of MSI-78, LL-37, and magainin-2 antimicrobial peptides.

Authors:  Laura Bedin Denardi; Carla Weiblen; Lara Baccarin Ianiski; Paula Cristina Stibbe; Stefania Campos Pinto; Janio M Santurio
Journal:  Braz J Microbiol       Date:  2022-01-11       Impact factor: 2.476

Review 5.  Biological activity and processing technologies of edible insects: a review.

Authors:  Jae Hoon Lee; Tae-Kyung Kim; Chang Hee Jeong; Hae In Yong; Ji Yoon Cha; Bum-Keun Kim; Yun-Sang Choi
Journal:  Food Sci Biotechnol       Date:  2021-08-05       Impact factor: 3.231

Review 6.  Phytochemical and Potential Properties of Seaweeds and Their Recent Applications: A Review.

Authors:  Hossam S El-Beltagi; Amal A Mohamed; Heba I Mohamed; Khaled M A Ramadan; Aminah A Barqawi; Abdallah Tageldein Mansour
Journal:  Mar Drugs       Date:  2022-05-24       Impact factor: 6.085

7.  Identification and Characterization of Novel Antioxidant Protein Hydrolysates from Kiwicha (Amaranthus caudatus L.).

Authors:  Sergio Montserrat-de la Paz; Alicia Martinez-Lopez; Alvaro Villanueva-Lazo; Justo Pedroche; Francisco Millan; Maria C Millan-Linares
Journal:  Antioxidants (Basel)       Date:  2021-04-22

8.  Large-scale mapping of bioactive peptides in structural and sequence space.

Authors:  Agustina E Nardo; M Cristina Añón; Gustavo Parisi
Journal:  PLoS One       Date:  2018-01-19       Impact factor: 3.240

Review 9.  Evaluation of the use of therapeutic peptides for cancer treatment.

Authors:  Susan Marqus; Elena Pirogova; Terrence J Piva
Journal:  J Biomed Sci       Date:  2017-03-21       Impact factor: 8.410

10.  Tryptophan-Containing Dual Neuroprotective Peptides: Prolyl Endopeptidase Inhibition and Caenorhabditis elegans Protection from β-Amyloid Peptide Toxicity.

Authors:  Paloma Manzanares; Roberto Martínez; Sandra Garrigues; Salvador Genovés; Daniel Ramón; Jose F Marcos; Patricia Martorell
Journal:  Int J Mol Sci       Date:  2018-05-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.